RecruitingPhase 3NCT06801626

Novel Strategies for Reducing Burn Scar Itch


Sponsor

The University of Texas Medical Branch, Galveston

Enrollment

44 participants

Start Date

Mar 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of the study is to see whether using diphenhydramine (Benadryl), famotidine (Pepcid), and cromolyn sodium will decrease burn scar itch.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria3

  • Participant has provided informed consent in a manner approved by the IRB and is willing and able to comply with the trial procedures.
  • Adults: ≥18 to <80 years of age.
  • Has an itchy burn scar.

Exclusion Criteria10

  • Failure to obtain consent or unable to return for follow up assessments.
  • Patient is unable to follow the protocol required assessments.
  • Member of a vulnerable class (e.g., prisoners, pregnant participant, etc.).
  • Any medical condition that, in the opinion of the investigator or physician, would place the participant at increased risk for participation.
  • Concurrent participation in another interventional clinical trial (to avoid confounding factors that may influence outcomes).
  • History of prior non-compliance or the presence or history of psychiatric condition (including drug or alcohol addiction) that would, in the opinion of the investigator, make it difficult for the participant to comply with the study procedures or follow the investigators instructions.
  • Age < 18 or ≥ 80 years.
  • Taking one of the following medications: cefuroxime, dasatinib, delavirdine, neratinib, pazopanib, risedronate, or tizanidine.
  • Has a pre-existing inflammatory or itchy skin disease.
  • Is taking an H2 antihistamine for another indication.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

COMBINATION_PRODUCTFamotidine and 4% topical cromolyn sodium

Patients will be instructed to take a 20mg famotidine capsule twice daily, and to use the lotion (4% cromolyn sodium) twice daily.

OTHERPlacebo

Treatment with active H1 antihistamine plus administration of placebo famotidine and placebo cromolyn sodium.


Locations(1)

University of Texas Medical Branch, Galveston

Galveston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06801626


Related Trials